FASN and cancer: In this study, we hypothesized that the compensatory adaptive response of lipid metabolism by FASN inhibitors in cancer cells can be counteracted by reducing FASN levels using IU1, a USP14 inhibitor, and therefore inhibiting FASN and USP14 together will dramatically suppress the cancer cell growth.